A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non–Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis-Reference-Cited by-同舟云学术

A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non–Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis

Published:2017-10-06 Issue:1 Volume:32 Page:27-34
ISSN:0894-1939
Container-title:Journal of Investigative Surgery
language:en
Short-container-title:Journal of Investigative Surgery

Author:

Wen Shi-Wang¹,Han Li²,Lv Hui- Lai¹,Xu Yan-Zhao¹,Li Zhen-Hua¹,Wang Ming-Bo¹,Zhu Yong-Gang¹,Su Peng¹,Tian Zi-Qiang¹,Zhang Yue-Feng¹

Affiliation:

1. Department of Thoracic Surgery, The Forth Hospital of Hebei Medical University, Shijiazhuang, China

2. Department of Emergency, The Forth Hospital of Hebei Medical University, Shijiazhuang, China

Publisher

Informa UK Limited

Subject

Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/08941939.2017.1370519

Reference30 articles.

1. STS Database Risk Models: Predictors of Mortality and Major Morbidity for Lung Cancer Resection

2. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications

3. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

4. Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

5. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study;Lung Cancer;2024-05

2. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

3. Prise en charge des stades précoces des cancers bronchiques non à petites cellules : radiothérapie en conditions stéréotaxiques vs chirurgie;Revue des Maladies Respiratoires Actualités;2023-10

4. Accelerated hypofractionated radiotherapy with 3 Gy per fraction for central/ultra-central lung tumors: toxicity to mediastinal organs;Japanese Journal of Clinical Oncology;2022-12-06

5. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies;Jornal Brasileiro de Pneumologia;2022-06-30